These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Ruts L; van Koningsveld R; van Doorn PA Neurology; 2005 Jul; 65(1):138-40. PubMed ID: 16009902 [TBL] [Abstract][Full Text] [Related]
27. Expression analysis of BDNF, BACE1 and their antisense transcripts in inflammatory demyelinating polyradiculoneuropathy. Ghafouri-Fard S; Mazdeh M; Nicknafs F; Nazer N; Sayad A; Taheri M Mult Scler Relat Disord; 2021 Jan; 47():102613. PubMed ID: 33160139 [TBL] [Abstract][Full Text] [Related]
28. iMAX: A new tool for assessment of motor axon excitability. A multicenter prospective study. Tyberghein M; Grapperon AM; Bouquiaux O; Puma A; Attarian S; Wang FC Clin Neurophysiol; 2022 Jan; 133():20-28. PubMed ID: 34800836 [TBL] [Abstract][Full Text] [Related]
29. New criteria for early electrodiagnosis of acute inflammatory demyelinating polyneuropathy. Al-Shekhlee A; Hachwi RN; Preston DC; Katirji B Muscle Nerve; 2005 Jul; 32(1):66-72. PubMed ID: 15880488 [TBL] [Abstract][Full Text] [Related]
30. Guillain-Barre or CIDP? That is the question. Smith BE Neurology; 2010 May; 74(21):1664-5. PubMed ID: 20445150 [No Abstract] [Full Text] [Related]
31. Diagnostic value of myotactic reflexes in axonal and demyelinating polyneuropathy. van Dijk GW; Wokke JH; Notermans NC; van Gijn J; Franssen H Neurology; 1999 Oct; 53(7):1573-6. PubMed ID: 10534270 [TBL] [Abstract][Full Text] [Related]
32. Motor unit number index (MUNIX): principle, method, and findings in healthy subjects and in patients with motor neuron disease. Nandedkar SD; Barkhaus PE; Stålberg EV Muscle Nerve; 2010 Nov; 42(5):798-807. PubMed ID: 20976783 [TBL] [Abstract][Full Text] [Related]
33. Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay. Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R Front Immunol; 2023; 14():1241199. PubMed ID: 38077366 [TBL] [Abstract][Full Text] [Related]
34. Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy. Comi C; Gaviani P; Leone M; Ferretti M; Castelli L; Mesturini R; Ubezio G; Chiocchetti A; Osio M; Muscia F; Bogliun G; Corso G; Gavazzi A; Mariani C; Cantello R; Monaco F; Dianzani U J Peripher Nerv Syst; 2006 Mar; 11(1):53-60. PubMed ID: 16519782 [TBL] [Abstract][Full Text] [Related]
36. High Levels of Il-19 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy. Sangsefidi S; Ghafouri-Fard S; Komaki A; Mazdeh M; Taheri M; Eftekharian MM J Mol Neurosci; 2020 Dec; 70(12):1997-2000. PubMed ID: 32472395 [TBL] [Abstract][Full Text] [Related]
37. A Diagnostic Panel for Acquired Immune-Mediated Polyneuropathies Based on the Expression of lncRNAs. Hussen BM; Nicknafs F; Hidayat HJ; Sayad A; Ghafouri-Fard S; Taheri M Front Immunol; 2021; 12():643615. PubMed ID: 33708228 [TBL] [Abstract][Full Text] [Related]
38. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome. Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422 [TBL] [Abstract][Full Text] [Related]
39. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes. Kuwabara S; Ogawara K; Sung JY; Mori M; Kanai K; Hattori T; Yuki N; Lin CS; Burke D; Bostock H Ann Neurol; 2002 Aug; 52(2):180-7. PubMed ID: 12210788 [TBL] [Abstract][Full Text] [Related]
40. Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy. Rajabally YA; Shah RS Muscle Nerve; 2010 Aug; 42(2):252-6. PubMed ID: 20544936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]